ClinicalTrials.gg
CompletedNCT03034785Updated May 3, 2022

Flexible Electronics for Early Assessment

An interventional study of FlexiMitt in Very Low Birth Weight Infant, sponsored by Wyss Institute at Harvard University. Completed at 2 sites in United States. Open to participants aged 13 Months to 60 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-03.

Sponsored by Wyss Institute at Harvard University · Not applicable, Interventional, and Device feasibility

How we know

From the registry’s dates

  • Primary completion was May 2021, 5 years 6 months ago, and no results have been posted to the registry.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
33
Allocation
Non-randomized
Ages
13 Months to 60 Months
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 32 studies in Birth Weight with a site in United States — 6 open to participants now, 6 under way, none of them phase 3. Birth Weight · United States.

Enrollment
12th of 19
33 · median 49
Started
2017
with 3 others
No phase
15 of 32
4 open now
Registered
18th of 32
by date

Among the 32 studies in Birth Weight with a site in United States, this one is the 12th largest by enrollment of the 19 interventional ones that give a count, is one of 4 that started in 2017, is one of 15 with no phase, and was the 18th registered.

Birth Weight

185 studies on the registry are indexed under Birth Weight; 24 are open to participants now.

Browse Birth Weight studies →

Open to participants now

6 of the 32 studies in Birth Weight with a site in United States are open now. Recruiting first, the newest first:

1 more — sign in →

All 6 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 18 Birth Weight studies recruiting now, 7 (39%) set no upper age limit and 11 (61%) stop at 75 or younger; 11 take children under 18; 4 take healthy volunteers.

This study: 13 Months to 60 Months · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 32 studies in Birth Weight with a site in United States, or all of them as a file.
02

Study summary

The morbidities associated with very low birth weight (VLBW) infants constitute a major health problem and a significant emotional and financial burden for families and our nation. The key to reducing this burden is early diagnosis. This research will be the first step towards intervention for cerebral growth and long-term neurodevelopmental morbidities of VLBW infants.

The proposed research is to design and fabricate a new technological innovation in wearable soft-sensors, called flexi-mitts, for measuring force modulation and joint angles of the hand (wrist and fingers) of toddlers. Building upon the investigators' ongoing work, they plan to engineer stretchable electronics for safe, toddler-scaled flexi-mitts to measure planning and force modulation.

The investigators' new flexi-mitt technology has the potential to provide a new diagnostic technology and the development of clinical assessment norms. With additional trials of the technology in large numbers of young children, it may be possible for clinicians and day care providers to eventually make measurements of planning and force modulation in play settings.

03

Conditions studied

  • Very Low Birth Weight Infant

Browse trials for

04

Who can participate

Ages eligible
13 Months to 60 Months
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Children Born Prematurely ("Preterm") -

Pilot Studies:

  • Ages 13-60 months (with the target ages around 18, 24, and 30 months)
  • Very low birth weight (less than 1500 grams)
  • Born between 28 and 33 weeks
  • Parent/Legal guardian provides written consent
  • Parent/Legal guardian is willing to facilitate testing with child (and may be included in photos/videos as a result)
  • Otherwise healthy condition

Longitudinal Study:

  • Ages 13-60 months (with the target age around 24 months) at the time of enrollment
  • Very low birth weight (less than 1500 grams)
  • Born between 28 and 33 weeks
  • Parent/Legal guardian provides written consent
  • Parent/Legal guardian is willing to facilitate testing with child (and may be included in photos/videos as a result)
  • Otherwise healthy condition

Typically Developing Children ("Term") -

Pilot Studies:

  • Ages 13-60 months (with the target ages around 18, 24, and 30 months)
  • Born at full term (37 weeks or later)
  • Healthy, with no history of neurological problems or musculoskeletal disorders, self-reported by parent or legal guardian
  • Parent/Legal guardian provides written consent
  • Parent/Legal guardian is willing to facilitate testing with child (and may be included in photos/videos as a result)

Longitudinal Study:

  • Ages 13-60 months (with the target age around 24 months) at time of enrollment
  • Born at full term (37 weeks or later)
  • Healthy, with no history of neurological problems or musculoskeletal disorders, self-reported by parent or legal guardian
  • Parent/Legal guardian provides written consent
  • Parent/Legal guardian is willing to facilitate testing with child (and may be included in photos/videos as a result)

Exclusion criteria

Exclusion Criteria:

Both Preterm and Term

  • Child has a history of/or currently exhibits any severe neurological complications, such as perinatal intraventricular hemorrhage (Grade 3 or 4) or periventricular leukomalacia
  • The participant is a child of a PI or other IRB-approved study team member
  • Parent/legal guardian does not provide consent or is unwilling to facilitate testing with child
05

Study design

Phase
Not applicable
Primary purpose
Device feasibility
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
33 participants (actual)

Study arms

  • No intervention
    Group 1

    Term

  • No intervention
    Group 2

    Preterm

  • Experimental
    Group 3

    Term

    Device: FlexiMitt

  • Experimental
    Group 4

    Preterm

    Device: FlexiMitt

Interventions

  • DeviceFlexiMitt

    The proposed research designs and fabricates a new technological innovation in wearable soft-sensors, called flexi-mitts, for measuring force modulation and joint angles of the hand (wrist and fingers) of toddlers.

06

What researchers measure

Primary outcomes

  1. Design and Fabricate FlexiMitts

    To measure joint angles and force

    Time frame: Anticipated Year 1

  2. Demonstrate Safety

    Bench tests of material failure (i.e., stretch deformity and compositional integrity)

    Time frame: Anticipated Year 1

  3. Examine group differences between Groups 1 and 2

    To examine group differences in force modulation and joint angles

    Time frame: Anticipated Year 2 through 4

  4. Examine longitudinal differences between Groups 1 and 2

    To examine longitudinal changes in force modulation and joint angles at 24 and 30 months

    Time frame: Anticipated Year 2 through 4

07

Study locations

2 sites
  • Beth Israel Deaconess Medical Center
    Boston, Massachusetts 02115, United States
  • Wyss Institute for Biologically Inspired Engineering at Harvard University
    Boston, Massachusetts 02115, United States
08

References and documents

Publications

  • Lawn JE, Kinney M. Preterm birth: now the leading cause of child death worldwide. Sci Transl Med. 2014 Nov 19;6(263):263ed21. doi: 10.1126/scitranslmed.aaa2563. No abstract available. PubMed 25411468 ↗
  • Rubens CE, Sadovsky Y, Muglia L, Gravett MG, Lackritz E, Gravett C. Prevention of preterm birth: harnessing science to address the global epidemic. Sci Transl Med. 2014 Nov 12;6(262):262sr5. doi: 10.1126/scitranslmed.3009871. PubMed 25391484 ↗
  • Back SA. Cerebral white and gray matter injury in newborns: new insights into pathophysiology and management. Clin Perinatol. 2014 Mar;41(1):1-24. doi: 10.1016/j.clp.2013.11.001. PubMed 24524444 ↗
  • Gordon AM, Duff SV. Fingertip forces during object manipulation in children with hemiplegic cerebral palsy. I: anticipatory scaling. Dev Med Child Neurol. 1999 Mar;41(3):166-75. doi: 10.1017/s0012162299000353. PubMed 10210249 ↗
  • Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, Hale EC, Newman NS, Schibler K, Carlo WA, Kennedy KA, Poindexter BB, Finer NN, Ehrenkranz RA, Duara S, Sanchez PJ, O'Shea TM, Goldberg RN, Van Meurs KP, Faix RG, Phelps DL, Frantz ID 3rd, Watterberg KL, Saha S, Das A, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010 Sep;126(3):443-56. doi: 10.1542/peds.2009-2959. Epub 2010 Aug 23. PubMed 20732945 ↗
  • Nordstrand L, Holmefur M, Kits A, Eliasson AC. Improvements in bimanual hand function after baby-CIMT in two-year old children with unilateral cerebral palsy: A retrospective study. Res Dev Disabil. 2015 Jun-Jul;41-42:86-93. doi: 10.1016/j.ridd.2015.05.003. Epub 2015 Jun 19. PubMed 26100242 ↗
  • Ulrich BD. Opportunities for early intervention based on theory, basic neuroscience, and clinical science. Phys Ther. 2010 Dec;90(12):1868-80. doi: 10.2522/ptj.20100040. Epub 2010 Oct 21. PubMed 20966210 ↗
  • Adolph KE, Berger SE, Leo AJ. Developmental continuity? Crawling, cruising, and walking. Dev Sci. 2011 Mar;14(2):306-18. doi: 10.1111/j.1467-7687.2010.00981.x. PubMed 21399716 ↗
  • Goldfield EC, Wolff PH. A dynamical systems perspective on infant action and it's development. Oxford Wiley-Blackwell; 2004
  • Thelen E, Smith L. A dynamic systems approach to the development of cognition and action. Cambridge, MA: MIT Press 1994
  • Slota GP, Latash ML, Zatsiorsky VM. Grip forces during object manipulation: experiment, mathematical model, and validation. Exp Brain Res. 2011 Aug;213(1):125-39. doi: 10.1007/s00221-011-2784-y. Epub 2011 Jul 7. PubMed 21735245 ↗
  • Santello M, Baud-Bovy G, Jorntell H. Neural bases of hand synergies. Front Comput Neurosci. 2013 Apr 8;7:23. doi: 10.3389/fncom.2013.00023. eCollection 2013. PubMed 23579545 ↗
  • Eliasson AC, Gordon AM, Forssberg H. Basic co-ordination of manipulative forces of children with cerebral palsy. Dev Med Child Neurol. 1991 Aug;33(8):661-70. doi: 10.1111/j.1469-8749.1991.tb14943.x. PubMed 1916022 ↗
  • Forssberg H, Eliasson AC, Kinoshita H, Johansson RS, Westling G. Development of human precision grip. I: Basic coordination of force. Exp Brain Res. 1991;85(2):451-7. doi: 10.1007/BF00229422. PubMed 1893993 ↗
  • Yoshikawa T, Nagai K. Manipulating and grasping forces in manipulation by multifingered robot hands. IEEE Transactions on Robotics and Automation 7:67-77, 1991.
  • Chen YP, Keen R, Rosander K, von Hofsten C. Movement planning reflects skill level and age changes in toddlers. Child Dev. 2010 Nov-Dec;81(6):1846-58. doi: 10.1111/j.1467-8624.2010.01514.x. PubMed 21077868 ↗
  • Jung WP, Kahrs BA, Lockman JJ. Manual action, fitting, and spatial planning: relating objects by young children. Cognition. 2015 Jan;134:128-39. doi: 10.1016/j.cognition.2014.09.004. Epub 2014 Oct 19. PubMed 25460386 ↗
  • Park WL, Chen BR, Wood RJ. Design and fabrication of soft artificial skin using embedded micro channels and liquid conductors. IEEE Sensors Journal 12(8):2711-2718, 2012.
  • Park YL, Majidi C, Kramer R, Berard P, Wood RJ. Hyperelastic pressure sensing with a liquid-embedded elastomer. Journal of Micromechanics and Microengineering 20(12), 2010.
  • Majidi C, Kramer R, Wood RJ. A non-differential elastomer curvature sensor for softer-than-skin electronics. Smart Materials and Structures 20(10), 2011
  • Vogt D, Park YL, Wood RJ. Design and characterization of a soft multi-axis force sensor using embedded microfluidic channels. IEEE Sensors Journal 13(10):4056-4064, 2013
  • Endo Y, Tada M, Mochimaru M. Dhaiba: Development of Virtual Ergonomic Assessment System with Human Models Digital Human Modeling 1-8, 2014.
  • Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (Methodological) 57(1):289-300, 1995.
  • Diggle P, Liang K-Y, Zeger SL. Analysis of longitudinal data. Clarendon Press; 1994.
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2017 to primary completion in May 2021, 45 months.

Of 43 non-industry interventional studies with no phase under Birth Weight, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 36. This study's 45 months is above that.

Counting every sponsor, half of 44 studies reached it within 19 months; a quarter within 15 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 17, 2017
First posted
Jan 27, 2017
StartActual
Aug 2, 2017
Primary completionActual
May 4, 2021
CompletionActual
May 4, 2021
Last update
May 3, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 3, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03034785
Lead sponsor
Wyss Institute at Harvard University
Responsible party
Eugene Goldfield (Associate Professor of Psychology in Psychiatry, Wyss Institute at Harvard University) — Principal investigator
First posted
Jan 27, 2017
Start date
Aug 2, 2017
Primary completion
May 4, 2021
Completion
May 4, 2021
Last update
May 3, 2022

Study contacts

Eugene Goldfield, Ph.D.
principal investigator · Wyss Institute for Biologically Inspired Engineering

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion